Wednesday, 4 March 2026
PERSPECTA
News from every angle
All
World
Politics
Business
Technology
Finance
Science
Health
Sport
Culture
Opinion
Environment
← Back to headlines
Arcturus outlines 12-week Phase II CF trial launch and expects regulatory clarity for ARCT-810 in 2026
4 Mar, 04:15 — 4 Mar, 04:15
Post
Share
Copy link
Embed
ℹ
Only 1 source covers this story
Read at source (1 outlet)
seeking-alpha
3h ago
Arcturus outlines 12-week Phase II CF trial launch and expects regulatory clarity for ARCT-810 in 2026
Read full article →
Related Stories
I've gained 5 kilos, can I take Ozempic?
22m ago
Study shows low awareness of obesity as a disease
23m ago
Malaika Arora believes ‘just 10 minutes of this Chinese exercise replaces your entire medicine cabinet’; expert weighs in
23m ago
New! BABĒ serum's dermatological power adapted to your skin
24m ago
Wednesday, 4 March 2026
Explore
Log in
Sign up
PERSPECTA
News from every angle
